Loading company…
UProtech researches and develops PROTAC drugs.
UProtech focuses on proteolysis targeting chimera drugs, including ubiquitin ligase ligands for tumors and immune diseases. Jianping Jin and Shixian Lin co-founded the company in Hangzhou, China, in 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in